Ascentage Pharma Announces NMPA Approval for Blood Cancer Drug

Ascentage Pharma Announces NMPA Approval for Blood Cancer Drug

By Karen Roman Ascentage Pharma Group International (Nasdaq: AAPG) said China’s National Medical Products Administration (NMPA) approved the use of lisaftoclax for the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. The authorization makes lisaftoclax the first inhibitor of...

Deborah Geraghty Named President & CEO of Radiant Biotherapeutics

Deborah Geraghty Named President & CEO of Radiant Biotherapeutics

By Karen Roman Toronto-based biotech company Radiant Biotherapeutics announced the designation of Deborah Geraghty, Ph.D., as President and Chief Executive Officer. The company also appointed Stefan Larson, Ph.D., as Chair of the Board of Directors, and Ingmar Bruns, M.D., Ph.D.,...

Study Shows Results for SkylineDx’s Test for Early-Stage Melanoma

Study Shows Results for SkylineDx’s Test for Early-Stage Melanoma

By Karen Roman Oncology-focused biotech company SkylineDx said an independent study shows that Merlin CP-GEP, the company’s test for treatment decisions in early-stage melanoma, correctly categorizes patients with skin melanoma for sentinel lymph node biopsy (SLNB). Merlin acts as a...

GameSquare Steps Up Crypto Strategy Through Dialectic Partnership

GameSquare Steps Up Crypto Strategy Through Dialectic Partnership

By Karen Roman GameSquare Holdings, Inc. (Nasdaq: GAME) said it is partnering with Dialectic to start crypto growth and treasury initiatives. The company  said it added Ryan Zurrer (Dialectic founder, formerly of Polychain Capital & Web3 Foundation) and Rhydon Lee...

Input your search keywords and press Enter.